- Report
- July 2024
- 100 Pages
Global
From €2651EUR$3,000USD£2,336GBP
€3314EUR$3,750USD£2,919GBP
- Report
- July 2024
- 115 Pages
Asia Pacific
From €4198EUR$4,750USD£3,698GBP
- Report
- July 2024
- 110 Pages
From €4198EUR$4,750USD£3,698GBP
- Report
- July 2024
- 120 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- February 2024
- 114 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- February 2024
- 115 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- February 2024
- 130 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- February 2024
- 114 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4198EUR$4,750USD£3,698GBP
- Report
- April 2023
- 113 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- April 2023
- 120 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- August 2022
- 115 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- May 2024
- 289 Pages
Global
From €4418EUR$5,000USD£3,893GBP
- Report
- December 2024
- 80 Pages
India
From €3093EUR$3,500USD£2,725GBP
- Report
- November 2024
- 85 Pages
United States
From €3093EUR$3,500USD£2,725GBP
- Report
- February 2024
- 186 Pages
Global
From €3977EUR$4,500USD£3,503GBP
From €3093EUR$3,500USD£2,725GBP
- Report
- November 2024
- 159 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- July 2024
- 166 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- May 2024
- 176 Pages
Global
From €2209EUR$2,500USD£1,946GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more